top of page

Incubate Comment in Response to Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients

Incubate Coalition
May 6
0 min read

ree

ree

Recent Posts

One-Pager: United States Policies Slow Biotech While China Accelerates

One-Pager: United States Policies Slow Biotech While China Accelerates

Incubate Releases Statement on Trump Administration's "Most Favored Nation" Pricing Deal

Incubate Releases Statement on Trump Administration's "Most Favored Nation" Pricing Deal

Incubate Releases Statement on President Trump's New Pharmaceutical Tariffs: Tariffs Threaten to Undermine U.S. Biopharmaceutical Leadership

Incubate Releases Statement on President Trump's New Pharmaceutical Tariffs: Tariffs Threaten to Undermine U.S. Biopharmaceutical Leadership

Comments

bottom of page